18,400 resources
By Version
By Authority
Start Prev Rows 7400 - 7600 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth |
|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1452 | MRSA (Tests by Culture and Identification Method) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1453 | MRSA (Tests for Methicillin Resistance Gene) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1454 | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1458 | Tests for Cefoxitin Susceptibility [OrdQn] | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1459 | Organisms (Tests in Blood by Culture and Identification) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1460 | Bacteria (Tests in Blood by Culture and Identification Method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1461 | Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1462 | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1463 | VRE (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1464 | VRE (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1465 | VRE (Tests by Culture and Identification Method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1466 | Enterococcus species (Tests by Culture and Identification Method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1468 | Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1469 | Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1470 | Enterococcus species (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1471 | Amebiasis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1473 | Amebiasis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1476 | Amebiasis (Tests for Entamoeba histolytica Nucleic Acid) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1482 | Norovirus (Tests for Norovirus Nucleic Acid) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1485 | Norovirus (Organism or Substance in Lab Results) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1487 | Clostridioides difficile infection (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1491 | C. diff infection (Tests for C diff Toxin Nucleic Acid) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1492 | C. diff infection (Tests for C diff Toxin Nucleic Acid in Stool) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1505 | Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1507 | Arsenic Exposure and Toxicity (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1509 | Arsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1513 | Urine (Specimen Type) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1514 | Mercury Exposure and Toxicity (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1515 | Cryptococcosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1516 | Cryptococcosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1520 | Cryptococcosis (Tests for Cryptococcus species by Culture and Identification Method) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1523 | Cryptococcosis (Tests for Cryptococcus species Nucleic Acid) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1524 | Cryptococcosis (Tests for Cryptococcus species Antigen) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1525 | Mercury Exposure and Toxicity (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1528 | Mercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1532 | Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1533 | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1534 | Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1538 | Drug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.154 | Hepatitis C Virus Infection (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1540 | Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1541 | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1542 | Drug Overdose and Poisoning [Non opioid] [Hallucinogen] (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1543 | Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1544 | Drug Overdose and Poisoning [Non opioid] [Analgesic] (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1545 | Drug Overdose and Poisoning [Non opioid] [Other Drug] (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1546 | Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1551 | Meningitis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1552 | Bacterial Meningitis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1553 | Fungal Meningitis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1554 | Parasitic Meningitis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1555 | Bacterial Meningitis (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1559 | Photophobia (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1562 | Bacteria [Causing Meningitis] (Organism or Substance in Lab Results) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1563 | Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1564 | Viruses [Causing Meningitis] (Organism or Substance in Lab Results) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1565 | Viruses [Causing Meningitis] (Tests for Nucleic Acid) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1566 | Viruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1567 | Bacteria [Causing Meningitis] (Tests by Culture and Identification Method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1574 | Invasive Group B Streptococcus (Disorders) (ICD10CM)) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1577 | Group A Streptococcus (Tests for Group A Strep by Culture and Identification Method) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1578 | Group B Streptococcus (Tests for Group B Strep by Culture and Identification Method) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1580 | Animal Bite [Dog] (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1581 | Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1582 | Animal Bite [Excluding Mammals] (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1584 | Animal Bite [Unspecified Animal] (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1585 | Animal Bite [Dog] (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1586 | Animal Bite [Mammal, Excluding Dogs] (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1587 | Animal Bite [Excluding Mammals] (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1588 | Cadmium Exposure and Toxicity (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1604 | Vaccine Adverse Event (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1605 | Vaccine Adverse Event (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1606 | Vaccinia disease or adverse event (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.161 | Vibriosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1612 | Blepharitis [Unspecified Cause] (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1613 | Keratitis [Unspecified Cause] (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1614 | Keratitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1620 | Anaphylaxis [Unspecified Cause] (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1626 | Thrombocytopenic Purpura [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1640 | Typhus Fever (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1641 | Typhus Fever (Tests for Rickettsia Typhus Group IgG Antibody) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1642 | Typhus Fever (Tests for Rickettsia Typhus Group IgM Antibody) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1643 | Typhus Fever (Tests for Rickettsia Typhus Fever Group IgG Antibody [Quantitative] by Immunofluorescence) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1651 | Chagas Disease (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1654 | Chagas Disease (Tests for Trypanosoma cruzi Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1661 | Cervical lymphadenopathy [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1662 | Conjunctival injection (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1663 | Drying of lips (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1667 | Edema of hands or feet (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1676 | Tests for Acinetobacter baumannii Nucleic Acid | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1677 | Tests for Pseudomonas aeruginosa by Culture and Identification Method | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1678 | Tests for Pseudomonas aeruginosa Nucleic Acid | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1679 | Pseudomonas aeruginosa (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1687 | NU_Gunshot Wound (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1688 | NU_Gunshot Wound (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.169 | Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.170 | Chlamydia trachomatis Infection (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1700 | Encephalitis [Viral] (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1702 | Encephalitis [Parasitic] (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1712 | Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1714 | Parasites [Causing Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1715 | Viruses [Causing Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1716 | Drowning and Submersion (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1717 | Drowning and Submersion (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1718 | Motor Vehicle Injury (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1719 | Motor Vehicle Injury (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1720 | Enterovirus Infection [Non polio] (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1721 | Enterovirus Infection [Non polio] (Disorders) (ICD10CM) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1722 | Enterovirus Infection [Non polio] (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1723 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1725 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus Nucleic Acid) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1726 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus in Cerebrospinal Fluid Nucleic Acid) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1735 | Clostridium perfringens Infection (Tests for C perfringens by Culture and Identification Method) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1739 | Head Injury (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1740 | Head Injury (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1742 | Brain Injury [Traumatic] (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1745 | Rotavirus Disease (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1746 | Rotavirus Disease (Tests for Rotavirus Nucleic Acid) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1748 | Chemical Pneumonitis (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1749 | Chemical Pneumonitis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1753 | Staphylococcal Enterotoxin B Poisoning (Tests for Staph aureus Enterotoxin B Nucleic Acid) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1755 | Vomitus (Specimen Type) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1758 | Asbestosis (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.176 | West Nile Virus Infection (Disorders) (ICD10CM) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1763 | Byssinosis (Disorders) (ICD10CM) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1769 | Farmers Lung (Tests for Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1772 | Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1773 | CLABSI (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1775 | Ophthalmia neonatorum (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1778 | Genital herpes (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1779 | Genital herpes (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1781 | Herpes (Tests for Herpes simplex virus Nucleic Acid) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1785 | Elevated liver enzyme (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1786 | Elevated liver enzyme (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1788 | Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1789 | Granuloma Inguinale (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1791 | Ulcer [Genital, Perineal, or Perianal Area] (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1792 | Ulcer [Genital, Perineal, or Perianal Area] (ICD10CM) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1797 | Bronchial Wash (Specimen Type) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1800 | Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1803 | Bacteria (Tests in Sputum Specimen by Culture and Identification Method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1819 | Louseborne relapsing fever (Tests for Borrelia species) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1820 | Louseborne relapsing fever (Tests for Borrelia species in Blood) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1823 | Borrelia species (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1824 | Spirochetes (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1829 | Polyarthritis [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1835 | Rheumatoid nodules (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1842 | Ventilator associated event (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1844 | Leishmaniasis (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1846 | Leishmaniasis (Tests for Leishmania species Nucleic Acid) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1847 | Leishmaniasis (Tests for Leishmania species Antibody) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1848 | Leishmania species (Tests by Microscopic Observation in Tissue) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.185 | Brucellosis (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1864 | Taeniasis (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1866 | Taeniasis (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.187 | Dengue Virus Infection (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1875 | Cysticercosis (Tests for Taenia solium Antibody) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1878 | Surgical Site Infection (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1880 | Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acid | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1881 | NU_Tests for Enterobacteriaceae species Nucleic Acid | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1882 | Carbapenemase production (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1892 | Toxoplasmosis (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1893 | Toxoplasmosis (Disorders) (ICD10CM) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1895 | Toxoplasmosis (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1897 | Toxoplasmosis (Tests by Microscopic Observation) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1898 | Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1901 | Toxoplasmosis (Tests for Toxoplasma gondii Antibody) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1902 | Orthopox (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1908 | Organisms (Tests by Electron Microscopic Observation) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1919 | Fungi [Causing Meningitis] (Tests by Culture and Identification Method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1923 | Coronary artery aneurysm (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1924 | Coronary artery dilatation (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1925 | Ectatic coronary artery (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1926 | Left ventricular ejection fraction [Decreased Level] (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1927 | Coronary artery aneurysm (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1928 | Shock (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1929 | Shock (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1930 | Troponin [Elevated Level] (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1931 | Oral mucosa Inflammation (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1932 | Oral mucosa Inflammation (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1933 | C reactive protein (Tests by Any Method) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1934 | Lymphocytes [Concentration] (Tests by Any Method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1935 | Strongyloidiasis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1936 | Strongyloidiasis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1937 | Strongyloidiasis (Tests for Strongyloides Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1938 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1939 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1940 | Organisms (Tests by Microscopic Observation in Stool) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1941 | Strongyloidiasis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1942 | Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1943 | Jamestown Canyon Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1944 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1945 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1946 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1947 | Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1948 | Keystone Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1949 | La Crosse Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1950 | Snowshoe hare Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1951 | Trivittatus Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1952 | La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid) | active | 2023-01 | hl7 |
FHIR